Drug recall · September 13, 2023
Digoxin Tablets recall
Why: Labeling: Label Mix-Up- Bottles labeled as Digoxin Tablets, USP 0.125 mg contain Digoxin Tablets, USP 0.25mg and bottles labeled as Digoxin Tablets, USP 0.25mg contain Digoxin Tablets, USP 0.125mg.
Class I: a reasonable chance the product could cause serious harm or death.
The recall
- Product
Digoxin Tablets, USP 0.125mg, 100-count bottles, Rx Only, Manufactured for/Distributed by: Marlex Pharmaceuticals, Inc. New Castle, DE NDC# 10135-0747-01
- Lots / codes
Lot # E3810, expiration date 02/2025
- Quantity
- 94/100 count bottles
- Company
- Marlex Pharmaceuticals, Inc., New Castle, DE
- Distribution
- Nationwide in the US.
- Initiated
- August 25, 2023 · Voluntary: Firm initiated
- Classified
- September 18, 2023
- Reported
- September 13, 2023
- Ended
- April 17, 2024
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Digoxin
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.